BET-IN-16 structure
|
Common Name | BET-IN-16 | ||
|---|---|---|---|---|
| CAS Number | 2089390-09-8 | Molecular Weight | 515.56 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C31H25N5O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BET-IN-16BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1]. |
| Name | BET-IN-16 |
|---|
| Description | BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Ben Powell, et al. Combinational drug anticancer therapies. Patent, WO2022040512A1. |
| Molecular Formula | C31H25N5O3 |
|---|---|
| Molecular Weight | 515.56 |